CVS Caremark underappreciated, says Credit Suisse Credit Suisse said CVS Caremark's (CVS) valuation discount versus Walgreen (WAG) is the largest in years and that shares are underappreciated. The analysts sees upcoming catalysts that include generic procurement savings, traffic gains, and strong cash flows. Shares are Outperform rated with a $60 price target.
News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.